tiprankstipranks
Nomura Micro Science Co., Ltd. (JP:6254)
:6254
Japanese Market

Nomura Micro Science Co., Ltd. (6254) AI Stock Analysis

2 Followers

Top Page

JP:6254

Nomura Micro Science Co., Ltd.

(6254)

Select Model
Select Model
Select Model
Outperform 73 (OpenAI - 5.2)
Rating:73Outperform
Price Target:
¥3,501.00
▲(19.41% Upside)
Action:ReiteratedDate:01/16/26
Overall score is driven primarily by strong income-statement performance and an attractive valuation (low P/E with a dividend). The main risk tempering the score is weak cash-flow generation (negative operating and free cash flow), while technicals remain bullish but show overbought signals that could pressure the stock in the near term.
Positive Factors
Revenue & Margin Improvement
Sustained top-line expansion accompanied by rising gross and net margins indicates improving operational efficiency and pricing or mix advantages. That margin durability supports reinvestment in projects and services, strengthening profitability over the next several quarters.
Negative Factors
Weak Cash Flow Generation
Persistent negative operating and free cash flow reduces internal funding for capex and working capital, increasing reliance on external financing. Even with improvement, continuing cash conversion weakness can limit investment, constrain growth pacing and pressure liquidity during downturns.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue & Margin Improvement
Sustained top-line expansion accompanied by rising gross and net margins indicates improving operational efficiency and pricing or mix advantages. That margin durability supports reinvestment in projects and services, strengthening profitability over the next several quarters.
Read all positive factors

Nomura Micro Science Co., Ltd. (6254) vs. iShares MSCI Japan ETF (EWJ)

Nomura Micro Science Co., Ltd. Business Overview & Revenue Model

Company Description
Nomura Micro Science Co., Ltd. engages in the design, installation, and sale of water treatment technologies in Japan, South Korea, Taiwan, China, and the United States. The company offers water treatment plants and equipment, including pure and u...
How the Company Makes Money
Nomura Micro Science primarily makes money by delivering end-to-end ultra-pure water and industrial water treatment solutions. A major revenue stream is engineering and construction (EPC-style) work, where it earns project revenue from designing a...

Nomura Micro Science Co., Ltd. Financial Statement Overview

Summary
Strong revenue growth and improving profit margins (solid EBIT/EBITDA) support a high score. Balance sheet is generally stable with moderate leverage and strong ROE, but rising debt warrants monitoring. Cash flow is the key drag, with negative operating cash flow and free cash flow despite improvement from 2024 to 2025.
Income Statement
85
Very Positive
Balance Sheet
75
Positive
Cash Flow
60
Neutral
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue101.13B96.36B73.02B49.60B31.90B30.36B
Gross Profit22.16B21.11B15.41B10.37B7.66B7.13B
EBITDA18.51B17.03B10.96B6.74B4.61B3.75B
Net Income10.25B10.20B7.98B5.81B3.29B2.62B
Balance Sheet
Total Assets103.87B116.78B70.60B41.92B27.24B24.92B
Cash, Cash Equivalents and Short-Term Investments18.89B17.33B12.14B14.12B10.08B9.86B
Total Debt47.98B53.20B22.40B3.47B2.69B2.63B
Total Liabilities68.92B79.77B41.68B20.52B11.31B11.73B
Stockholders Equity34.95B37.01B28.92B21.40B15.93B13.19B
Cash Flow
Free Cash Flow0.00-22.31B-19.01B3.66B954.82M5.80B
Operating Cash Flow0.00-20.20B-18.66B4.68B1.13B5.96B
Investing Cash Flow0.00-2.74B386.99M64.81M134.01M-433.48M
Financing Cash Flow0.0027.18B17.45B-24.90M-881.82M-937.84M

Nomura Micro Science Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2932.00
Price Trends
50DMA
3195.96
Negative
100DMA
3133.08
Positive
200DMA
3048.36
Positive
Market Momentum
MACD
10.66
Negative
RSI
52.46
Neutral
STOCH
55.99
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6254, the sentiment is Positive. The current price of 2932 is below the 20-day moving average (MA) of 2991.15, below the 50-day MA of 3195.96, and below the 200-day MA of 3048.36, indicating a neutral trend. The MACD of 10.66 indicates Negative momentum. The RSI at 52.46 is Neutral, neither overbought nor oversold. The STOCH value of 55.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6254.

Nomura Micro Science Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
¥59.91B10.642.79%2.85%3.17%
75
Outperform
¥65.86B13.243.95%-1.67%-4.39%
73
Outperform
¥136.04B19.552.86%89.90%190.48%
70
Outperform
¥166.55B7.708.17%2.04%1.48%58.59%
70
Outperform
¥88.33B4.093.09%6.35%-34.20%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
52
Neutral
¥10.27B42.221.65%3.96%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:6254
Nomura Micro Science Co., Ltd.
3,430.00
1,477.20
75.65%
JP:6376
Nikkiso Co., Ltd.
2,728.00
1,692.32
163.40%
JP:6237
Iwaki Co. Ltd.
2,735.00
1,058.75
63.16%
JP:6363
Torishima Pump Mfg.Co., Ltd.
3,365.00
1,651.89
96.43%
JP:6381
ANEST IWATA Corp.
1,655.00
686.77
70.93%
JP:6495
Miyairi Valve Mfg.Co., Ltd.
214.00
121.86
132.25%

Nomura Micro Science Co., Ltd. Corporate Events

Nomura Micro Science Posts Strong Nine-Month Earnings and Confirms Full-Year Outlook
Feb 13, 2026
Nomura Micro Science reported strong consolidated results for the nine months ended December 31, 2025, with net sales rising 28.9% year on year to ¥41.0 billion and profit attributable to owners of parent jumping 38.7% to ¥2.9 billion. E...
Nomura Micro Science Extends Repayment Deadlines on Major U.S.-Dollar Loans
Feb 13, 2026
Nomura Micro Science Co., Ltd. has postponed the repayment dates on existing U.S. dollar-denominated loans tied to a large water treatment systems project in the United States. The decision, approved by its board on February 13, 2026, is intended ...
Nomura Micro Science Delivers Strong Nine-Month Earnings but Guides for Softer Full-Year
Feb 13, 2026
Nomura Micro Science reported strong consolidated results for the nine months ended December 31, 2025, with net sales rising 28.9% year-on-year to ¥41.0 billion and profit attributable to owners of parent jumping 38.7% to ¥2.9 billion, l...
Nomura Micro Science Delays Loan Repayments for U.S. Water Treatment Project
Feb 13, 2026
Nomura Micro Science Co., Ltd. has decided to revise the repayment dates on U.S. dollar-denominated loans tied to working capital for a large water treatment systems project handled by its U.S. subsidiary. The move reflects the group’s curre...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 16, 2026